Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Resistance Training × 1 year × Clear all

Sponsor

Conditions

Motor Activity 5 Breast Neoplasms 4 Pancreatic Neoplasms 3 Obesity 3 Neoplasms 3 Brain Neoplasms 3 Sarcopenia 2 Prostatic Neoplasms 2 Multiple Myeloma 2 Lymphedema 2 Colorectal Neoplasms 2 Weight Loss 1 Smoldering Multiple Myeloma 1 Skin Neoplasms 1 Rehabilitation Exercise 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Overweight 1 Neoplasms, Plasma Cell 1 Melanoma 1 Lymphoma, B-Cell 1 Lymphoma 1 Lung Neoplasms 1 Leukemia 1 Hodgkin Disease 1 Hematopoietic and Lymphatic System Neoplasm 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Cardiotoxicity 1

Interventions

pembrolizumab 38 Gemcitabine 20 enfortumab vedotin 19 Cisplatin 17 Nivolumab 16 atezolizumab 14 Magnetic Resonance Spectroscopy 14 avelumab 13 Carboplatin 12 Specimen Handling 10 Docetaxel 10 sacituzumab govitecan 9 Paclitaxel 7 Ipilimumab 7 Fluorodeoxyglucose F18 5 pemigatinib 4 toripalimab 3 erdafitinib 3 durvalumab 3 cabozantinib 3 X-Rays 3 Taxes 3 Mitomycin 3 Immunoglobulin G 3 CTLA-4 Antigen 3 Biopsy 3 tislelizumab 2 lenvatinib 2 eribulin 2 dodecyl maltoside 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡